Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, December 9, 2019
[ Mon, Dec 09th 2019
] - WOPRAI
[ Mon, Dec 09th 2019
] - WOPRAI
[ Mon, Dec 09th 2019
] - WOPRAI
[ Mon, Dec 09th 2019
] - WOPRAI
[ Mon, Dec 09th 2019
] - WOPRAI
[ Mon, Dec 09th 2019
] - WOPRAI
[ Mon, Dec 09th 2019
] - WOPRAI
Fri, December 6, 2019
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
[ Fri, Dec 06th 2019
] - WOPRAI
Matt Borsch Initiated (AMED) at Hold and Held Target at $170 on, Dec 6th, 2019
Matt Borsch of BMO Capital, Initiated "Amedisys, Inc." (AMED) at Hold and Held Target at $170 on, Dec 6th, 2019.
Matt has made no other calls on AMED in the last 4 months.
There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, 2 agree with Matt's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Andrew Mok of "UBS" Maintained at Hold with Increased Target to $154 on, Thursday, November 7th, 2019
- Scott Fidel of "Stephens & Co." Initiated at Hold and Held Target at $145 on, Tuesday, October 22nd, 2019
These are the ratings of the 3 analyists that currently disagree with Matt
- Joanna Gajuk of "B of A Securities" Maintained at Strong Buy with Increased Target to $178 on, Tuesday, November 26th, 2019
- Whit Mayo of "Baird" Upgraded from Hold to Buy on, Friday, November 1st, 2019
- Justin Bowers of "Deutsche Bank" Initiated at Strong Buy and Held Target at $155 on, Tuesday, September 17th, 2019
